Komori
Wolves Hand (194A) · InitiativeFirst stated

Bringing R&D results into practical use through the integration of CRO and SMO capabilities

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Bringing in CRO and SMO capabilities through the acquisition of メディトリックスA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「By incorporating into the One Health platform the expertise held by メディトリックス株式会社, whose share acquisition was completed on 22 July 2026, in CRO and SMO functions, clinical research support, clinical trial operations and data management, the Company will strengthen its ability to connect research and development成果 with product commercialisation and social implementation.」

    The acquisition of メディトリックス after the reporting company's fiscal year indicates the integration of functions that connect research and development成果 with product commercialisation and social implementation.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Wolves Hand yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.